This is the authors' abstract. We don't add key points for this paper.
[Extract] The medical research world is responding to the covid-19 pandemic at breathtaking speed. There has been a maelstrom of global research, with mixed consequences. Positives include the greater provision of open access to covid-19 studies, some increased collaboration, expedited governance and ethics approvals of new clinical studies, and wider use of preprints. But many problems have become evident. Before the pandemic, it was estimated that up to 85% of research was wasted because of poor questions, poor study design, inefficiency of regulation and conduct, and non or poor reporting of results.1 Many of these problems are amplified in covid-19 research, with time pressures and inadequate research infrastructure contributing.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Glasziou et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: